Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NESC phase II preoperative chemoradiotherapy study in gastric adenocarcinoma
2006-005168-16Phase 2Active
- Sponsor
- Institut Sainte-Catherine
- Start
- Jul 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin, fluorouracil and oxaliplatin in gastric adenocarcinoma, sponsored by Institut Sainte-Catherine. Primary endpoints: Pathological response on surgical specimen and Histological response rate. Started Jul 2007; status: active.
02
Drugs
docetaxelcisplatinfluorouraciloxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on 2006-005168-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005168-16.